304
Views
112
CrossRef citations to date
0
Altmetric
Research Article

Cationic Vectors in Ocular Drug Delivery

, , &
Pages 623-633 | Received 13 Jul 2004, Accepted 01 Oct 2004, Published online: 03 Oct 2008

References

  • Abdulrazik, M., Tamilvanan, S., Khoury, K. and Benita, S. (2001) “Ocular delivery of cyclosporin A. II. Effect of submicron emulsion’s surface charge on ocular distribution of topical cyclosporin A”, STP Pharma Sci. 11, 427– 432.
  • Ahmed, I. and Patton, T.F. (1984) “Effect of pH and buffer on the precorneal disposition and ocular penetration of pilocarpine in rabbits”, Int. J. Pharm. 19, 215– 227.
  • Ahmed, I. and Patton, T.F. (1985) “Importance of the noncorneal absorption route in topical ophthalmic drug delivery”, Investig. Ophthalmol. Vis. Sci. 26, 584– 587.
  • Ahmed, I., Gokhale, R.D., Shah, M.V. and Patton, T.F. (1987) “Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea”, J. Pharm. Sci. 76, 583– 586.
  • Almofti, M.R., Harashima, H., Shinohara, Y., Almofti, A., Baba, Y. and Kiwada, H. (2003) “Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization”, Arch. Biochem. Biophys. 410, 246– 253.
  • Ashton, P., Podder, S.K. and Lee, V.H. (1991) “Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration”, Pharm. Res. 8, 1166– 1174.
  • Baeyens, V. and Gurny, R. (1997) “Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations”, Pharm. Acta Helv. 72, 191– 202.
  • Behrens, I., Pena, A.I., Alonso, M.J. and Kissel, T. (2002) “Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport”, Pharm. Res. 19, 1185– 1193.
  • Calvo, P., Thomas, C., Alonso, M.J., Vila-Jato, J.L. and Robinson, J.R. (1994) “Study of the mechanism of interaction of poly(e-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy”, Int. J. Pharm. 55, 283– 291.
  • Calvo, P., Alonso, M.J., Vila-Jato, J.L. and Robinson, J.R. (1996a) “Improved ocular bioavailability of indomethacin by novel ocular drug carriers”, J. Pharm. Pharmacol. 48, 1147– 1152.
  • Calvo, P., Vila-Jato, J.L. and Alonso, M.J. (1996b) “Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers”, J. Pharm. Sci. 85, 530– 536.
  • Calvo, P., Vila-Jato, J.L. and Alonso, M.J. (1997) “Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers”, Int. J. Pharm. 153, 41– 50.
  • Carney, L.G., Mauger, T.F. and Hill, R.M. (1989) “Buffering in human tears: pH responses to acid and base challenge”, Investig. Ophthalmol. Vis. Sci. 30, 747– 754.
  • Chien, D.S., Homsy, J.J., Gluchowski, C. and Tang-Liu, D.D. (1990) “Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes”, Curr. Eye Res. 9, 1051– 1059.
  • Chrai, S.S., Patton, T.F., Mehta, A. and Robinson, J.R. (1973) “Lacrimal and instilled fluid dynamics in rabbit eyes”, J. Pharm. Sci. 62, 1112– 1121.
  • Conroy, C.W. and Maren, T.H. (1995) “Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor”, Exp. Eye Res. 61, 213– 222.
  • da Cruz, M.T., Simoes, S., Pires, P.P., Nir, S. and de Lima, M.C. (2001) “Kinetic analysis of the initial steps involved in lipoplex – cell interactions: effect of various factors that influence transfection activity”, Biochim. Biophys. Acta 1510, 136– 151.
  • de Campos, A.M., Sanchez, A. and Alonso, M.J. (2001) “Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A”, Int. J. Pharm. 224, 159– 168.
  • de Campos, A.M., Sanchez, A., Gref, R., Calvo, P. and Alonso, M.J. (2003) “The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa”, Eur. J. Pharm. Sci. 20, 73– 81.
  • Diebold, Y., Enriquez de Salamanca, A., Jarrin, M., Callejo, S., Vila, A. and Alonso, M.J. (2003) “Uptake of bioadhesive nanoparticles in a normal human conjunctiva (NHC) epithelial cell line”, ARVO Meeting Abstracts 44, 3785.
  • Diepold, R., Kreuter, J., Guggenbuhl, P. and Robinson, J.R. (1989) “Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes”, Int. J. Pharm. 54, 149– 153.
  • Ding, S. (1998) “Recent developments in ophthalmic drug delivery”, Pharm. Sci. Technol. Today 1, 328– 335.
  • Edward, A. and Prausnitz, M.R. (2001) “Predicted permeability of the cornea to topical drugs”, Pharm. Res. 18, 1497– 1508.
  • El-Gazayerly, O.N. and Hikal, A.H. (1997) “Preparation and evaluation of acetazolamide liposomes as an ocular delivery system”, Int. J. Pharm. 158, 121– 127.
  • Felt, O., Furrer, P., Mayer, J.M., Plazonnet, B., Buri, P. and Gurny, R. (1999) “Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention”, Int. J. Pharm. 180, 185– 193.
  • Fitzgerald, P., Hadgraft, J. and Wilson, C.G. (1987) “A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit”, J. Pharm. Pharmacol. 39, 487– 490.
  • Hamalainen, K.M., Kananen, K., Auriola, S., Kontturi, K. and Urtti, A. (1997) “Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera”, Investig. Ophthalmol. Vis. Sci. 38, 627– 634.
  • Hill, R.M. and Carney, L.G. (1980) “Human tear responses to alkali”, Investig. Ophthalmol. Vis. Sci. 19, 207– 210.
  • Huang, H.S., Schoenwald, R.D. and Lach, J.L. (1983) “Corneal penetration behavior of beta-blocking agents. II: assessment of barrier contributions”, J. Pharm. Sci. 72, 1272– 1279.
  • Huang, M., Ma, Z., Khor, E. and Lim, L.Y. (2002) “Uptake of FITC-chitosan nanoparticles by A549 cells”, Pharm. Res. 19, 1488– 1494.
  • Kaur, I.P., Garg, A., Singla, A.K. and Aggarwal, D. (2004) “Vesicular systems in ocular drug delivery: an overview”, Int. J. Pharm. 269, 1– 14.
  • Klang, S.H., Frucht-Pery, J., Hoffman, A. and Benita, S. (1994) “Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle”, J. Pharm. Pharmacol. 46, 986– 993.
  • Klang, S.H., Siganos, C.S., Benita, S. and Frucht-Pery, J. (1999) “Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn”, J. Control. Release 57, 19– 27.
  • Klang, S., Abdulrazik, M. and Benita, S. (2000) “Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution”, Pharm. Dev. Technol. 5, 521– 532.
  • Law, S.L., Huang, K.J. and Chiang, C.H. (2000) “Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption”, J. Control. Release 63, 135– 140.
  • Lehr, C.M., Bouwstra, J.A., Schacht, E.H. and Junginger, H.E. (1992) “In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers”, Int. J. Pharm. 78, 43– 48.
  • Liaw, J., Rojanasakul, Y. and Robinson, J.R. (1992) “The effect of drug charge type and charge density on corneal transport”, Int. J. Pharm. 88, 111– 124.
  • Longwell, A., Birss, S., Keller, N. and Moore, D. (1976) “Effect of topically applied pilocarpine on tear film pH”, J. Pharm. Sci. 65, 1654–1657.
  • Maren, T.H. and Jankowska, L. (1985) “Ocular pharmacology of sulfonamides: the cornea as barrier and depot”, Curr. Eye Res. 4, 399– 408.
  • Meisner, D. and Mezer, M. (1995) “Liposome ocular delivery systems”, Adv. Drug Deliv. Rev. 16, 75– 93.
  • Meisner, D., Pringle, J. and Mezei, M. (1989) “Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine”, Int. J. Pharm. 55, 105– 113.
  • Muchtar, S., Abdulrazik, M., Frucht-Pery, J. and Benita, S. (1997) “Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea”, J. Control. Release 44, 55– 64.
  • Nagarsenker, M.S., Londhe, V.Y. and Nadkarni, G.D. (1999) “Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery”, Int. J. Pharm. 190, 63– 71.
  • Pandit, J.C., Nagyova, B., Bron, A.J. and Tiffany, J.M. (1999) “Physical properties of stimulated and unstimulated tears”, Exp. Eye Res. 68, 247– 253.
  • Patton, T.F. and Robinson, J.R. (1976) “Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes”, J. Pharm. Sci. 65, 1295– 1301.
  • Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A. and Puglisi, G. (2002a) “Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen”, Eur. J. Pharm. Sci. 16, 53– 61.
  • Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A. and Puglisi, G. (2002b) “Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application”, Biomaterials 23, 3247– 3255.
  • Qaddoumi, M.G., Gukasyan, H.J., Davda, J., Labhasetwar, V., Kim, K.J. and Lee, V.H. (2003) “Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis”, Mol. Vis. 9, 559– 568.
  • Rabinovich-Guilatt, L., Couvreur, P., Lambert, G., Goldstein, D., Benita, S. and Dubernet, C. (2004) “Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions”, Chem. Phys. Lipids 131, 1– 13.
  • Robinson, J.R. (1993) “Ocular anatomy and physiology relevant to ocular drug delivery”, In: Mitra, A.K., ed., Ophthalmic Drug Delivery Systems (Marcel Dekker, New York), pp 29–57.
  • Rojanasakul, Y. and Robinson, J.R. (1989) “Transport mechanisms of the cornea: characterization of barrier permselectivity”, Int. J. Pharm. 55, 237– 246.
  • Schaeffer, H.E. and Krohn, D.L. (1982) “Liposomes in topical drug delivery”, Investig. Ophthalmol. Vis. Sci. 22, 220– 227.
  • Schoenwald, R.D. and Huang, H.S. (1983) “Corneal penetration behavior of beta-blocking agents I: Physiochemical factors”, J. Pharm. Sci. 72, 1266– 1272.
  • Schoenwald, R.D. and Ward, R.L. (1978) “Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients”, J. Pharm. Sci. 67, 786– 788.
  • Singh, M., Meisner, D., Faulkner, G. and Mezei, M. (1993) “Liposomal drug delivery to the eye and lungs: a preliminary electron microscopy study”, J. Microencapsul. 10, 35– 44.
  • Small, D.M., Dais, M., Wong, M. and Tang-Liu, D.D. (1997) “Influence of pH and buffer concentration on the ocular bioavailability of ophthalmic AGN 191103 formulations in albino rabbits”, Int. J. Pharm. 149, 195– 201.
  • Suhonen, P., Jarvinen, T., Peura, P. and Urtti, A. (1991) “Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro”, Int. J. Pharm. 74, 221– 228.
  • Taniguchi, K., Yamamoto, Y., Itakura, K., Miichi, H. and Hayashi, S. (1988) “Assessment of ocular irritability of liposome preparations”, J. Pharmacobiodyn. 11, 607– 611.
  • Tiffany, J.M. (1994) “Composition and biophysical properties of the tear film: knowledge and uncertainty”, In: Sullivan, D.A., ed., Lacrimal Gland, Tear Film, and Dry Eye Syndromes (Plenum Press, New York), pp 231–238.
  • Velpandian, T., Gupta, S.K., Gupta, Y.K., Biswas, N.R. and Agarwal, H.C. (1999) “Ocular drug targeting by liposomes and their corneal interactions”, J. Microencapsul. 16, 243– 250.
  • Yamada, M., Kawai, M., Mochizuki, H., Hata, Y. and Mashima, Y. (1998) “Fluorophotometric measurement of the buffering action of human tears in vivo”, Curr. Eye Res. 17, 1005– 1009.
  • Zaki, I., Fitzgerald, P., Hardy, J.G. and Wilson, C.G. (1986) “A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man”, J. Pharm. Pharmacol. 38, 463– 466.
  • Zimmer, A. and Kreuter, J. (1995) “Microspheres and nanoparticles used in ocular delivery systems”, Adv. Drug Deliv. Rev. 16, 61– 73.
  • Zimmer, A., Kreuter, J. and Robinson, J.R. (1991) “Studies on the transport pathway of PBCA nanoparticles in ocular tissues”, J. Microencapsul. 8, 497– 504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.